•
We all know that press releases are, by definition, designed to highlight positive news. And that’s being generous. But a pair of…
•
If any company thinks a press release is protected speech under the First Amendment of the U.S. Constitution and, therefore, can’t be used…
•
Big pharma continues to dabble, tentatively, with social media. The latest example is GlaxoSmithKline, which this week launched its very own…
•
Can information about medicines that is communicated by third parties – such as journalists – constitute advertising? How about when the…
•
Several months ago, Ray Kerins, a top Pfizer public relations exec, bemoaned the perception of the pharmaceutical industry in a…
•
Is there a wanton witch hunt against academic experts by the media? That’s what a panel will explore this coming November…
•
The ongoing economic crunch has claimed yet another casualty – the Integrity in Science Watch program that was run by…
•
As newspapers shrink, fold or migrate entirely to the Internet, what will happen to science journalism? Like other topics, coverage…
•
Do doctors really want their patients involved in decision making? And even if many do, what are the barriers that…
•
One day, President Barack Obama is calling for open government and transparency. The next, the acting FDA commissioner, Frank Torti,…